Advertisement

Topics

Latest "Triangle Pharmaceuticals Incorporated" News Stories

00:08 EST 16th December 2017 | BioPortfolio

Here are the most relevant search results for "Triangle Pharmaceuticals Incorporated" found in our extensive news archives from over 250 global news sources.

More Information about Triangle Pharmaceuticals Incorporated on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Triangle Pharmaceuticals Incorporated for you to read. Along with our medical data and news we also list Triangle Pharmaceuticals Incorporated Clinical Trials, which are updated daily. BioPortfolio also has a large database of Triangle Pharmaceuticals Incorporated Companies for you to search.

Showing "Triangle Pharmaceuticals Incorporated" News Articles 1–25 of 9,700+

Friday 15th December 2017

Fresenius Kabi AG Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14112017] Prices from USD $250

SummaryFresenius Kabi AG Fresenius Kabi, a wholly owned subsidiary of Fresenius SE Co KGaA, develops, manufactures and markets pharmaceuticals products and medical devices. The company's product portfolio includes intravenously administered drugs, infusion therapy products, medical devices and clinical nutrition products. It covers therapeutic areas such as blood volume substitution, fluid manage...


UniQuest Pty Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 28112017] Prices from USD $250

SummaryUniQuest Pty Ltd UniQuest, a subsidiary of The University of Queensland is a commercialization company that offers consultancy services. The company commercializes intellectual property and research outcomes of University of Queensland. It offers services such as eShop, witness, contract research, service provision business, collaborative research and development, license and option to lice...

Global and Asia Sodium Benzoate Market Status and Future Forecast 20132023 [Report Updated: 08112017] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPart 3:Asia Market by company, Type, Application RegionPart 410:Key Regions of Asia Market by Type, ApplicationPart 11:Company information, Sales, Cost, Margin etc.Part 12:ConclusionMarket Segment as fo...


AntriaBio Inc ANTB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27112017] Prices from USD $250

SummaryAntriaBio Inc AntriaBio, formerly AntriaBio Delaware Inc is a biopharmaceutical company that develops drug therapies for the treatment of diabetes and metabolic diseases. The company's lead product candidate include AB10, human recombinant insulin for use in type 1 and type 2 diabetes for the control of hyperglycemia; and AB301, a human glucagonlike peptide1 agonist for the treatment of pat...

Enlivant Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112017] Prices from USD $250

SummaryEnlivant Inc Enlivant is an assisted living facilities provider that offers senior living residence services. The center provides senior housing options, choosing assisted living and short term stay services. It also provides attentive and individualized care services. Enlivant offers assistance with activities of daily living, including dressing, bathing, and dining; nursing oversight; car...

ChemRar HighTech Center Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 15112017] Prices from USD $250

SummaryChemRar HighTech Center CHTC is a discovers and commercializes drugs for lifethreatening diseases. The company offers drugs for the treatment of cancer, central nervous system CNS, infectious, metabolic and cardiovascular diseases. It also offers preclinical and clinical research of new molecules including screening and identification of the important biological targets for new molecules, s...

Delcath Systems Inc DCTH Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 15112017] Prices from USD $250

SummaryDelcath Systems Inc Delcath is a specialty pharmaceutical and medical device company, which specializes in developing percutaneous perfusion technologies to treat primary and metastatic liver cancers. Its patented drug delivery platform delivers ultrahigh doses of anticancer drugs to the liver, while preventing them from entering the patient's bloodstream. Delcath's proprietary product, Mel...

PsychoGenics Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 28112017] Prices from USD $250

SummaryPsychoGenics Inc PsychoGenics is an preclinical contract research organization that offers contract research, standard and customized preclinical services and drug discovery services. The organization offers various behavioral tests to drug candidates in the areas of pain and inflammation, psychiatric and neurodegenerative disorders, and spinal cord and traumatic brain injury. Its phenocube...

Notice to Shareholders of Parnell Pharmaceuticals Holdings, Ltd regarding Extraordinary General ...

SYDNEY, Dec. 15, 2017/PRNewswire/ -- Parnell Pharmaceuticals Holdings Ltd. (OTC PINK:PARNF) Read more...

Uppsala University Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 28112017] Prices from USD $250

SummaryUppsala University is an educational service provider that offers education and research services. The university offers master programs in the areas of science and technology, arts, law, medicine, languages, social sciences and theology. It conducts pharmaceutical research projects in the areas of ageing related diseases, children's diseases, cancer and other tumor diseases, cardiovascular...

Pharmascience Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 28112017] Prices from USD $250

SummaryPharmascience Inc Pharmascience is a pharmaceutical company that develops, manufactures and markets medicinal products. The company offers generic, prescription, overthecounter and private label OTC products. It offers drugs in therapeutic areas of antiinflammatory, cancer, cardiovascular, pain management, allergies, antiinfectives, gastrointestinal, cough and cold, and others. It offers pr...

University of New Mexico Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 28112017] Prices from USD $250

SummaryUniversity of New Mexico UNM is an educational service provider that offers bachelors, masters, doctoral and professional degree programs in various fields. The university offers programs such as continuing education, evening and weekend degree programs, extended learning and Latin American studies, among others. It also conducts research studies in fields of intellectual property, technolo...

Sanford Health Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 28112017] Prices from USD $250

SummarySanford Health Sanford is a healthcare service provider that offers medical services. The center's medical services include allergy and immunology, acupuncture, adult trauma, airmed, anesthesiology, breast health, behavioral health, pediatric care, bladder health, bleeding disorders, botox cosmetic, breast cancer risk consultation, breast radiology, cancer risk assessment and cancer screeni...

Aura Biosciences Taps Cadmus Rich for Chief Medical Officer Post

Cadmus Rich has joined Aura Biosciences to become the Cambridge, MA, company’s chief medical officer. Rich most recently worked at Inotek Pharmaceuticals (NASDAQ: ITEK) in Lexington, MA, where he was vice president, medical affairs and clinical development. Aura’s lead drug, AU-11, is in early-stage clinical testing for ocular melanoma, a rare eye cancer.

Santhera Pharmaceuticals Holding AG SANN Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 15112017] Prices from USD $250

SummarySanthera Pharmaceuticals Holding AG Santhera is a pharmaceutical company that develops and commercializes novel pharmaceutical products indicated for patients with rare mitochondrial diseases. It specifically focuses in the area of neuromuscular and neuroophthalmological conditions. The company's lead product candidate, Raxone idebenone, is developed for the treatment of Leber's hereditary ...

University of Tennessee Research Foundation Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 28112017] Prices from USD $250

SummaryUniversity of Tennessee Research Foundation UTRF, a subsidiary of University of Tennessee is a non profit organization that promotes research and education. The organization offers agriculture, chemistry and materials; energy, animal health, engineering, human health, research tools and software and copyright technologies. It supports research activities of University of Tennessee in the ar...

ContraVir Pharmaceuticals Inc CTRV Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27112017] Prices from USD $250

SummaryContraVir Pharmaceuticals Inc ContraVir is a biopharmaceutical company that focusses on development and commercialization of targeted antiviral therapies. The company's pipeline product includes TXL, potent prodrug of antiviral tenofovir and CRV431 cyclophilin inhibitor that increases its potency and selective index against HBV. The company products are used for the treatment of chronic hep...

Canadian Pharmaceuticals Billionaire And Wife Found Dead In Toronto Mansion

Canadian billionaire Bernard "Barry" Sherman and his wife, Honey, were found dead in their Toronto home Friday, and police are reportedly investigating their deaths as suspicious.

sanofiaventis US LLC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 28112017] Prices from USD $250

SummarySanofiAventis US LLC Sanofi US, a subsidiary of Sanofi is a drug company that discovers, develops and distributes various therapeutic solutions. The company provides prescription products, vaccines and other products. Sanofi US's vaccines include ActHIB, Adacel, DAPTACEL, Decavac, Fluzone, Imogam, IPOL, Menactra, Menomune, TheraCys, Typhim Vi, YFVAX, and Pentacel among others. The company's...

Allergy Therapeutics Plc AGY Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 28112017] Prices from USD $250

SummaryAllergy Therapeutics Plc Allergy Therapeutics is a specialty pharmaceutical company that develops therapies for allergy treatment and allergy prevention. The company offers a wide range of aluminiumfree allergy vaccines and diagnostics. It uses Micro Crystalline Tyrosine MCT as an alternative of aluminium to develop aluminiumfree immunotherapy vaccines. Allergy Therapeutics product portfoli...

Global and Regional Fermentation Chemical Market Research Report 2017 [Report Updated: 07112017] Prices from USD $3500

SummaryMarket Segment as follows:By Region AsiaPacific North America Europe South America Middle East AfricaBy Type Alcohols Enzymes Organic AcidsBy Application Industrials Food Beverages Pharmaceuticals ChemicalsBy Company BASF Ajinomoto Dow Chemical AB Enzymes Archer Daniels Midland Company ADM Cargill DuPont Nutrition Health Novozym...

Akebia Therapeutics Inc AKBA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14112017] Prices from USD $250

SummaryAkebia Therapeutics Inc Akebia Therapeutics is a developer of biopharmaceutical therapeutics based on hypoxia inducible factor for patients with kidney disease. The company offer products such as vadadustat for the treatment of anemia associated with chronic kidney disease and is in phase III clinical studies. It offers AKB6899, second hypoxia provides factorprolyl hydroxylase product candi...

Global Alginate Market Analysis 20112017 and Forecast 20182023 [Report Updated: 25102017] Prices from USD $2980

SnapshotThe global Alginate market will reach xxx Million USD in 2017 and CAGR xx% 20112017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Alginate by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market pri...

TEVA Pharmaceuticals-Aktie: Aufhellung beim Sentiment! - Aktienanalyse

Zürich - TEVA Pharmaceuticals-Aktienanalyse des Analysten Vamil Divan von der Credit Suisse: Laut einer Aktienanalyse äußert Vamil Divan, Analyst bei der Credit Suisse, in Bezug auf die Aktien des ...

Dimerix Bioscience Pty Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27112017] Prices from USD $250

SummaryDimerix Bioscience Pty Ltd Dimerix, a subsidiary of Sun Biomedical Ltd is a biopharmaceutical company that offers drug discovery assays and progressing clinical programs. The company provides product development, discovery services, and others. It provides ReceptorHIT a cellbased assay applied to the stages of the drug development process. Dimerix's heteromer identification technology assay...


Quick Search
Advertisement
 

News Quicklinks